FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology and provides an ophthalmic composition for zwitterionic soft contact lenses, comprising pranoprofen and/or a pharmaceutically acceptable salt thereof, and glycyrrhizic acid and/or a pharmaceutically acceptable salt thereof, characterised in that the pH of said ophthalmic composition is 5.5 or higher.
EFFECT: invention provides a therapeutic effect of pranoprofen and/or salt thereof without side effects on zwitterionic soft contact lenses, effective prevention or treatment of eye inflammation, suppression of turbidity caused by pranoprofen and/or salt thereof, and a clear appearance.
8 cl, 4 tbl, 3 ex
